Insights from recent episode analysis
Audience Interest
Podcast Focus
Publishing Consistency
Platform Reach
Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.
Most discussed topics
Brands & references
Est. Listeners
Based on iTunes & Spotify (publisher stats).
- Per-Episode Audience
Est. listeners per new episode within ~30 days
10,001 - 25,000 - Monthly Reach
Unique listeners across all episodes (30 days)
25,001 - 75,000 - Active Followers
Loyal subscribers who consistently listen
15,001 - 40,000
Market Insights
Platform Distribution
Reach across major podcast platforms, updated hourly
Total Followers
—
Total Plays
—
Total Reviews
—
* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.
On the show
From 10 epsHosts
Recent guests
Recent episodes
GLP-1 Genetics: Predicting Weight Loss and Side Effects With 23andMe's Dr. Adam Auton
Apr 21, 2026
24m 36s
Do GLP-1 Medicines Actually Cause Muscle Loss? New Research With Dr. Henning Langer
Apr 14, 2026
36m 25s
How Often Should You Really Lift Weights? Feat. Dr. Stuart Phillips
Apr 2, 2026
51m 56s
Bimagrumab and Semaglutide: The BELIEVE Trial Results With Dr. Steven Heymsfield
Mar 23, 2026
38m 42s
Menopause, Muscle, and the Myths | Dr. Alyssa Olenick
Mar 13, 2026
49m 39s
Social Links & Contact
Official channels & resources
Official Website
Login
RSS Feed
Login
| Date | Episode | Topics | Guests | Brands | Places | Keywords | Sponsor | Length | |
|---|---|---|---|---|---|---|---|---|---|
| 4/21/26 | GLP-1 Genetics: Predicting Weight Loss and Side Effects With 23andMe's Dr. Adam Auton✨ | geneticsweight loss+4 | Dr. Adam Auton | 23andMe | — | GLP-1genetics+5 | — | 24m 36s | |
| 4/14/26 | Do GLP-1 Medicines Actually Cause Muscle Loss? New Research With Dr. Henning Langer✨ | GLP-1 medicinesmuscle loss+5 | Dr. Henning Langer | GLP-1 medicinessemaglutide+1 | — | GLP-1muscle loss+6 | — | 36m 25s | |
| 4/2/26 | How Often Should You Really Lift Weights? Feat. Dr. Stuart Phillips✨ | resistance trainingmuscle building+4 | Dr. Stuart Phillips | American College of Sports Medicine | — | weight liftingresistance training+6 | — | 51m 56s | |
| 3/23/26 | Bimagrumab and Semaglutide: The BELIEVE Trial Results With Dr. Steven Heymsfield✨ | weight lossclinical trials+3 | Dr. Steven Heymsfield | bimagrumabsemaglutide+1 | — | bimagrumabsemaglutide+5 | — | 38m 42s | |
| 3/13/26 | Menopause, Muscle, and the Myths | Dr. Alyssa Olenick✨ | menopausebody composition+3 | Dr. Alyssa Olenick | — | — | menopausemuscle+4 | — | 49m 39s | |
| 3/6/26 | The Truth About Creatine (Doctors Discuss)✨ | creatinesupplementation+3 | Dr. Lauren | — | — | creatinesupplementation+5 | — | 35m 06s | |
| 2/23/26 | Top Sleep Doctor: Stop Taking Melatonin Like This✨ | sleep hygieneCBT-I+5 | — | — | — | sleep advicemelatonin+7 | — | 48m 33s | |
| 2/12/26 | GLP-1s and Fertility What to Know Before Trying to Conceive✨ | fertilityPCOS+4 | Dr. Lucky Sekhon | The Lucky Egg | — | GLP-1fertility+6 | — | 54m 19s | |
| 1/30/26 | Reclaiming Excellence: A Conversation with Brad Stulberg✨ | excellencemotivation+3 | Brad Stulberg | — | — | excellencebiohacking+4 | — | 45m 13s | |
| 1/20/26 | Oral GLP-1 (Wegovy) Is Here: Dosing, Switching, and What to Expect✨ | GLP-1Wegovy+4 | Dr. Karl | WegovyZepbound+1 | — | WegovyGLP-1+5 | — | 25m 23s | |
Want analysis for the episodes below?Free for Pro Submit a request, we'll have your selected episodes analyzed within an hour. Free, at no cost to you, for Pro users. | |||||||||
| 1/12/26 | ![]() Breaking Down the New Food Pyramid (Great or Confusing) | The new U.S. Dietary Guidelines just dropped, and the internet is freaking out over the updated food pyramid. In this episode, we break down what the guidelines actually say, who they’re really written for (hint: mostly policymakers, not everyday people), and why the pyramid graphic can be more confusing than helpful. We also dig into the biggest inconsistencies like the push for more protein and “natural fats,” the mixed messaging on saturated fat, and the messy “processed foods” debate without a clear definition. Bottom line: there’s some reasonable advice here, but a lot of the hype is performative, and the real impact depends on how these guidelines get translated into actual policy like school lunches and federal programs. | — | ||||||
| 1/7/26 | ![]() Cortisol Myths vs Reality: What Your Adrenals Actually Do | We hear “high cortisol” blamed for everything, but your adrenal glands are supposed to make cortisol in a daily rhythm that helps you wake up, fuel exercise, and handle illness. In this episode, we break down what cortisol actually does, how real adrenal disorders like Cushing’s are diagnosed, and why random at home cortisol tests and “adrenal fatigue” claims are usually misleading. | — | ||||||
| 12/5/25 | ![]() GLP-1 Side Effects Deep Dive: Slimmer's Paralysis, Bladder Spasms, & Reactive Hypoglycemia. | In this episode, Dr. Spencer and Dr. Karl break down some of the strangest and most misunderstood GLP-1 side effects, from slimmer’s paralysis and foot drop to bladder spasms and post-bariatric reactive hypoglycemia. They walk through real patient cases, why these issues happen, and what clinicians and patients can do to spot them early and manage them safely. | — | ||||||
| 11/19/25 | ![]() GLP-1s and Breast Milk: What the New Research Actually Found | In this episode, we sit down with leading lactation researcher Dr. Kaytlin Krutsch break down the first real human data on GLP-1 medications in breast milk. She explains what the studies found, what women should consider before starting these medications postpartum, and why the actual risk may be far lower than most people think. | — | ||||||
| 11/12/25 | ![]() How to Build Healthy Routines That Actually Stick | In this episode, Dr. Spencer and Dr. Karl talk with Dr. Karin Nordin, behavioral change specialist and founder of Body Brain Alliance, about why most advice on motivation, discipline, and habits gets it wrong. They break down the science of behavior change, exploring how identity, self-efficacy, and “future self thinking” can help people finally follow through on healthy routines that last. | — | ||||||
| 11/3/25 | ![]() The Truth About Testosterone Therapy in Women (with Dr. Susan Davis) | In this episode, Dr. Spencer Nadolsky and Dr. Karl engage with Dr. Susan Davis, a leading endocrinologist and researcher in testosterone therapy for women. They explore the complexities of sexual dysfunction, the role of testosterone in women's health, and the nuances of diagnosing and treating low sexual desire. The conversation delves into the importance of understanding psychosocial factors, the limitations of current testosterone testing, and the appropriate dosing and administration of testosterone therapy. Dr. Davis emphasizes the need for evidence-based practices and the importance of individualized patient care in managing women's sexual health. | — | ||||||
| 10/23/25 | ![]() From Injections to Pills: Breaking Down the New Oral GLP-1 Data | Dr. Spencer and Dr. Karl sit down with Dr. Sean Wharton, lead author on the OASIS-4 and ATTAIN-1 trials, to unpack the groundbreaking data behind the new oral GLP-1 medications. They discuss how oral semaglutide and orforglipron compare to injectables, what makes these molecules unique, and why 2026 could be the year obesity care changes forever. | — | ||||||
| 10/13/25 | ![]() De-Emphasizing BMI, Prioritizing Health: What’s New in the ACE Obesity Guidelines | Dr. Spencer and Dr. Karl break down the brand-new ACE Obesity Clinical Practice Algorithm, which redefines how clinicians approach obesity as an adiposity-based chronic disease. From de-emphasizing BMI to focusing on personalized health, staging severity, and prioritizing strength training and lifestyle therapy, they unpack what these updates mean for both patients and providers. | — | ||||||
| 9/25/25 | ![]() Debunking The Myths of Metabolism and Weight Loss | In this episode, Dr. Spencer and Dr. Karl sit down with Dr. Kevin Hall and Julia Belluz to break down the science behind metabolism, weight loss, and their new book Food Intelligence. They clear up the myths around the Biggest Loser study, explain why appetite biology matters more than a “broken metabolism,” and explore how our food environment, from ultra-processed diets to cultural norms, shapes health outcomes. | — | ||||||
| 9/1/25 | ![]() Menopause Medicine Meets Obesity Care: Doctors React | Does menopausal hormone therapy change how women respond to GLP-1 medicines like tirzepatide and semaglutide? In this episode, Dr. Spencer Nadolsky and Dr. Karl Nadolsky sit down with Mayo Clinic’s Dr. Maria Daniela Hurtado Andrade and Dr. Regina Castaneda to discuss their latest research, the nuances behind the findings, and what it means for women navigating menopause and obesity care. Do you also want me to generate a few alternative title options that highlight their names (for authority) while still keeping the engagement factor? | — | ||||||
| 8/29/25 | ![]() Women’s Fitness Needs Debate: Dr. Stacy Sims vs. Dr. Lauren Colenso-Semple | Do women really need to train and eat differently than men? In this episode, Dr. Stacy Sims and Dr. Lauren Colenso-Semple join Spencer and Karl for a spirited debate on fasted training, protein timing, perimenopause, and whether women’s unique physiology calls for unique fitness strategies. | — | ||||||
| 8/22/25 | ![]() Do You Really Lose Muscle on Semaglutide or Tirzepatide? | Worried that GLP-1 medications like semaglutide or tirzepatide will make you lose muscle instead of fat? In this episode, we dive into real patient data, resistance training, and protein strategies to separate myth from reality. | — | ||||||
| 8/16/25 | ![]() Predatory Lab Testing: What They’re Not Telling You | Some health companies are selling massive lab panels directly to consumers often with questionable medical value and zero real follow-up. We sit down with the Barbell Medicine crew to expose the risks, the marketing tactics, and the right way to approach lab testing without getting scammed. | — | ||||||
| 8/8/25 | ![]() CVS Pulled the Plug on Zepbound?! | ChatGPT said: CVS Caremark just dropped Zepbound from its formulary, forcing countless patients to switch to Wegovy. In this episode, we break down why it happened, how PBMs are calling the shots, and what patients can actually do about it. | — | ||||||
| 8/3/25 | ![]() More Than Weight Loss? GLP-1s and Cardiovascular Risk | Monjaro just dropped hot new trial results and they might show it helps you live longer. We break down the Surpass CVOT, compare it to Trulicity, and explain what this all means for your heart, kidneys, and overall health. | — | ||||||
Showing 25 of 150
Sponsor Intelligence
Sign in to see which brands sponsor this podcast, their ad offers, and promo codes.
Chart Positions
13 placements across 13 markets.
Chart Positions
13 placements across 13 markets.

